<DOC>
	<DOCNO>NCT02871947</DOCNO>
	<brief_summary>Severe asthma heterogeneous disease characterize need treatment high dos inhale corticosteroid . It affect 5 % -10 % asthmatic patient , although account significant percentage consumption health care resource . Severe asthma comprises various clinical pathophysiological phenotype . In current study , aim clinical characteristic cytokes profile severe asthma patient .</brief_summary>
	<brief_title>Epidemiology Cytokines Analysis Severe Asthma Patients Taiwan</brief_title>
	<detailed_description>To investigate clinical phenotype inflammatory endotype analyze cytokine severe asthma patient , may improve characterization disease contribute improve selection appropriate treatment . It could also help link genotype phenotypic manifestation natural history prognosis . A great understanding phenotype severe asthma could enable identification biomarkers phenotype , identify association biokarkers clinical outcome severe asthma patient .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>1 . Asthma require treatment guideline suggest medication GINA step 45 asthma ( high dose ICS LABA leukotriene modifier/theophylline ) previous year systemic CS 50 % previous year prevent become `` uncontrolled '' remain `` uncontrolled '' despite therapy 2 . Uncontrolled asthma define least one following : ( 1 ) . Poor symptom control : ACQ consistently &gt; 1.5 , ACT &lt; 20 ( `` well control '' NAEPP/GINA guideline ) ( 2 ) . Frequent severe exacerbation : two burst systemic CS ( &gt; 3 day ) previous year ( 3 ) . Serious exacerbation : least one hospitalization , ICU stay mechanical ventilation previous year ( 4 ) . Airflow limitation : appropriate bronchodilator withhold FEV1 &lt; 80 % predict ( face reduce FEV1/FVC define less low limit normal ) ( 1 ) . mild moderate persistent asthma ( 2 ) . COPD lung disease ( 3 ) . malignancy ( 4 ) . longterm O2 therapy 15 hours/day ( 5 ) . longterm NIPPV use ( &gt; 6 hours/day ) ( 6 ) . inform consent follow regularly ( 7 ) . active TB infection disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>severe asthma</keyword>
</DOC>